首页 IDEXX实验室(usIDXX)-基本信息

IDEXX实验室(usIDXX)-基本信息

日报更新时间:

周报更新时间:04-11 03:39

行情信息

今开价:499.82

最高价:509.97

成交量:433352.0

昨收价:502.88

最低价:498.13

最新价:506.43

行情图标
概要信息

中文名称:IDEXX实验室


英文名称:IDEXX Laboratories


行业:医疗


简介:IDEXX Laboratories, Inc.位于特拉华州,于1983年注册


电话:1-207-5560300


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

美国爱德士生物科技公司(爱德士实验室公司)在动物健康、水和牛奶质量检测领域,是诊断和信息技术解决方案的全球领导者,在全球60多个地区进行运营。IDEXX Laboratories最大的业务部门帮助全球范围内50000多个宠物诊所推进医疗护理,提高员工生产力,增加诊所盈利。爱德士通过一个完整的诊断服务组合来实现,该组合包括宠物现场诊断,定点医护设备,参考实验室服务,数字放射技术和诊所管理方案。此外,爱德士是确保水质安全的微生物检测技术的全球领先者;也是确保乳品安全和经济动物健康的诊断试剂和健康监测体系的顶级供应商。爱德士实验室公司分为5个部门来运作:宠物集团(Companion Animal Group)、水质产品(Water Quality Products)、家畜(Livestock)、家禽和奶制品(Poultry and Dairy)以及其他部门(Other)。IDEXX Laboratories公司提供: 医护站兽医诊断产品,包括:仪器、耗材、快速检测、兽医参考实验室诊断和咨询服务。 执业管理系统和服务,以及提供给兽医的数字影像系统和生物材料测试,与供应医学研究社群的实验室动物的生物诊断工具和服务。 针对家畜、家禽和奶制品提供诊断,健康监测和食品安全检测产品。 提供测试水质中某些微生物污染物的产品与在医护点照护的电解质和被使用在人类在医护点照护的医学诊断市场上的血液气体分析仪。爱德士实验室 IDEXX Laboratories(IDXX)收购历史: 2011年11月,收购密苏里大学(University of Missouri)兽医学院(College of Veterinary Medicine)的研究和诊断实验室; 2013年8月,收购Madasa do Brasil Ltda。

交易日期 交易人 职位 类型 交易份额 价格
2019-07-29 Vandebroek (Sophie V) Director Buy 70 286.05
2019-07-29 Junius (Daniel M) Director Buy 22 286.05
2019-07-29 Essig (Stuart M) Director Buy 70 286.05
2019-05-31 Turner (Kathy V) Officer Buy 466 --
2019-05-31 Turner (Kathy V) Officer Sell 118 249.77
2019-05-30 Twigge Giovani Officer Sell 2600 250.14
2019-05-12 Henderson (Rebecca M) Director Sell 8790 241.57
2019-05-12 Henderson (Rebecca M) Director Buy 8790 43.68
2019-05-09 Lane (Michael J) Officer Sell 1812 245.41
2019-05-05 Twigge Giovani Officer Sell 2015 250.00
2019-05-02 McKeon (Brian P) Chief Financial Officer Sell 629 248.79
2019-05-02 McKeon (Brian P) Chief Financial Officer Sell 375 245.77
2019-05-02 McKeon (Brian P) Chief Financial Officer Buy 7504 44.05
2019-05-02 Ayers (Jonathan W) Chief Executive Officer Sell 11400 248.57
2019-05-02 McKeon (Brian P) Chief Financial Officer Sell 225 247.28
2019-05-02 McKeon (Brian P) Chief Financial Officer Sell 204 242.72
2019-05-02 Ayers (Jonathan W) Chief Executive Officer Sell 2600 247.81
2019-05-02 Ayers (Jonathan W) Chief Executive Officer Buy 28000 45.84
2019-05-02 Ayers (Jonathan W) Chief Executive Officer Sell 13900 249.62
2019-05-02 Ayers (Jonathan W) Chief Executive Officer Sell 100 250.02
2019-05-02 McKeon (Brian P) Chief Financial Officer Sell 300 244.57
2019-05-02 McKeon (Brian P) Chief Financial Officer Sell 5771 248.28
2019-04-29 Essig (Stuart M) Director Buy 81 232.00
2019-04-29 Junius (Daniel M) Director Buy 26 232.00
2019-04-29 Vandebroek (Sophie V) Director Buy 81 232.00

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Capital World Investors 1082373 1.26% 7838 0.73% 2019-03-31
BlackRock Fund Advisors 2393022 2.78% -1910946 -44.40% 2019-07-31
T. Rowe Price Associates, Inc. 2392988 2.78% 21096 0.89% 2019-03-31
Vanguard Investments Australia Ltd 2403386 2.79% 348 0.01% 2019-07-31
State Street Corporation 3705170 4.31% 132083 3.70% 2019-03-31
BAMCO Inc 4016927 4.67% -114303 -2.77% 2019-03-31
Fundsmith LLP 4467341 5.19% 35049 0.79% 2019-03-31
BlackRock Inc 6511387 7.57% -37635 -0.57% 2019-03-31
Vanguard Group Inc 9135240 10.62% 78089 0.86% 2019-03-31
Blair William & Co 1582222 1.84% 10586 0.67% 2019-03-31
Neuberger Berman Group LLC 1500543 1.74% -11175 -0.74% 2019-03-31
Neuberger Berman Investment Advisers LLC 1500543 1.74% -11175 -0.74% 2019-03-31
American Century Companies Inc 1483074 1.72% 780846 111.20% 2019-03-31
Ameriprise Financial Inc 1472954 1.71% -62508 -4.07% 2019-03-31
Columbia Mgmt Investment Advisers, LLC 1446097 1.68% -68693 -4.53% 2019-03-31
State Street Global Advisors 1429626 1.66% -2509 -0.18% 2019-07-31
Geode Capital Management, LLC 1377665 1.60% -948153 -40.77% 2019-03-31
Putnam Investment Management, LLC 1117385 1.30% 431185 62.84% 2019-07-31
Baron Capital Management Inc 1100000 1.28% -5000 -0.45% 2019-07-31
Renaissance Technologies Corp 1089125 1.27% -427204 -28.17% 2019-03-31
Amvescap Plc. 1132417 1.32% -102611 -8.31% 2018-12-31
BlackRock Asset Management Canada Ltd 2685709 3.12% 3784 0.14% 2019-05-31
BlackRock Japan Co Ltd 1262644 1.47% 1144 0.09% 2019-05-31
Goldman Sachs Asset Management, L.P. 1338529 1.56% -4054 -0.30% 2018-12-31
Goldman Sachs Group Inc 1532835 1.78% -43841 -2.78% 2018-12-31
Invesco Capital Management LLC 1083144 1.26% -62020 -5.42% 2019-03-31
Bank of New York Mellon Corp 1082526 1.26% -22161 -2.01% 2018-09-30
Fundsmith Equity Fund, L.P. 4429104 5.14% 4429104 -- 2018-06-30
Capital Research and Management Company 1059793 1.23% 1669 0.16% 2018-11-30
BlackRock Institutional Trust Company NA 2219873 2.57% -497707 -18.31% 2018-06-30
Neuberger Berman LLC 1615073 1.87% -35797 -2.17% 2018-03-31
State Street Corp 3426982 3.96% -79800 -2.28% 2018-06-30
Baron Capital Group 4700932 5.40% -989955 -17.40% 2017-12-31
Columbia Mangmt Investment Advisers, LLC 1609453 1.86% -75826 -4.50% 2018-06-30
Invesco PowerShares Capital Mgmt LLC 1116313 1.29% 404315 56.79% 2018-06-30
State Street Global Advisors (Aus) Ltd 1001209 1.16% 23817 2.44% 2018-09-12
Northern Trust Investments N A 1039797 1.20% 33222 3.30% 2018-06-30
Arrowstreet Capital Limited Partnership 1009333 1.16% -65656 -6.11% 2018-06-30
Goldman Sachs Asset Management LP 983201 1.13% 659847 204.06% 2018-06-30
Old Mutual Asset Managers UK Ltd 927868 1.07% -6302 -0.67% 2018-06-30
American Century Inv Mgt Inc 884600 1.02% -61791 -6.53% 2018-03-31
HHG PLC 889936 1.02% -172549 -16.24% 2017-12-31
NORGES BANK 801237 0.92% -154994 -16.21% 2017-12-31
Capital Counsel LLC 733063 0.84% -2775 -0.38% 2017-09-30
Goldman, Sachs & Co. 771760 0.88% 234410 43.62% 2017-06-30
Atlanta Capital Management Company,LLC 2231311 2.49% -274206 -10.94% 2016-09-30
Select Equity Group LP 2184013 2.43% -723904 -24.89% 2016-09-30
William Blair Investment Management, LLC 1711947 1.91% -221047 -11.44% 2016-09-30
Federated Global Inv Mgmt Corp 1146700 1.28% -41990 -3.53% 2016-09-30
State Street Global Markets, LLC 1036715 1.16% 28616 2.84% 2016-12-31
J.P. Morgan Investment Management Inc 1003596 1.12% -131893 -11.62% 2016-09-30
Brown Investment Advisory Incorporated 716740 0.80% -40952 -5.40% 2016-09-30
Royce & Associates, LLC 708990 0.79% -154822 -17.92% 2016-09-30
William Blair& Company, LLC 5605902 3.00% 439586805 0.10% 1999-11-30
The Vanguard Group 5909806 3.00% 463417437 0.10% 1999-11-30
BlackRock, Inc. 6184490 3.00% 484956783 0.10% 1999-11-30
Baron Capital Group, Inc. 7246008 3.00% 568195717 0.10% 1999-11-30
Ruane, Cunniff& Goldfarb Inc. 8896814 3.00% 697643670 0.10% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Vanguard Mid-Cap Growth Index Fund 547607 0.64% 21642 4.11% 2019-06-30
American Funds New Perspective Fund 1017000 1.18% -- -- 2019-06-30
Baron Small-Cap Growth Strategy-UBS 1100000 1.28% -5000 -0.45% 2019-06-30
Baron Growth Fund 1100000 1.28% -5000 -0.45% 2019-06-30
Vanguard 500 Index Fund 1691904 1.97% 17408 1.04% 2019-06-30
T. Rowe Price New Horizons Fund 1710387 1.99% 643300 60.29% 2019-06-30
Vanguard Mid-Cap Index Fund 2095100 2.43% 28017 1.36% 2019-06-30
Vanguard Total Stock Market Index Fund 2368567 2.75% 346 0.01% 2019-06-30
OMIM FundSmith Equity Feeder 4242323 4.93% -- -- 2019-03-31
Baron Asset Fund 976630 1.13% -- -- 2019-06-30
SPDR 954128 1.11% 884 0.09% 2019-07-31
Baron Partners Fund 900000 1.05% -- -- 2019-06-30
Vanguard Growth Index Fund 614563 0.71% 20457 3.44% 2019-06-30
iShares Core S&P 500 ETF 635203 0.74% -312 -0.05% 2019-07-30
Merian Global Equity Absolute Return Fd 656469 0.76% -940 -0.14% 2018-12-31
Principal MidCap Fund 671379 0.78% -1230 -0.18% 2019-06-30
Fidelity 696466 0.81% 10266 1.50% 2019-06-30
Neuberger Berman Genesis Fund 755959 0.88% -21800 -2.80% 2019-03-31
Invesco QQQ Trust 772463 0.90% 679 0.09% 2019-07-31
Vanguard Institutional Index Fund 803077 0.93% -5568 -0.69% 2019-06-30
Fundsmith Equity 4242323 4.93% -- -- 2019-03-31
Fundsmith Equity Sicav 4242323 4.93% -- -- 2018-12-31
iShares Core S&P 500 ETF (CAD-Hedged) 631322 0.73% 572 0.09% 2019-05-30
iShares S&P 500 ETF 631322 0.73% 572 0.09% 2019-05-30
iShares Core S&P US Total Market ETF 631322 0.73% 572 0.09% 2019-05-30
Fundsmith Equity Fund Feeder 4242323 4.93% -- -- 2018-12-31
iShares Core MSCI Kokusai ETF 631322 0.73% 572 0.09% 2019-05-30
iShares MSCI World ETF 624406 0.73% -1300 -0.21% 2019-04-25
Baron Small Cap Fund 550000 0.64% -25000 -4.35% 2018-12-31
Old Mutual Global Eq Abs Ret Fund 657409 0.76% -60862 -8.47% 2018-06-30
VA CollegeAmerica New Perspective Fd 1017000 1.18% -- -- 2018-12-31
OH Putnam Fidelity Spartan 500 Index 646025 0.75% 18691 2.98% 2019-01-31
Franklin DynaTech Fund 450000 0.52% -- -- 2018-12-31
Health Care Select Sector SPDR 488009 0.57% 11628 2.44% 2019-01-31
Franklin DynaTech 450000 0.52% -- -- 2018-12-31
Baron Partners Retail 900000 1.04% -- -- 2018-06-30
Vanguard Institutional Index I 840288 0.97% 1544 0.18% 2018-07-31
VA CollegeAmerica New Perspective 529E 1017000 1.17% -- -- 2018-06-30
Baron Asset Retail 1067630 1.23% -20000 -1.84% 2018-06-30
Baron Growth Retail 1200000 1.39% -50000 -4.00% 2018-06-30
Vanguard 500 Index Inv 1572454 1.82% 1479 0.09% 2018-07-31
Vanguard Mid Cap Index I 2060396 2.38% 12062 0.59% 2018-07-31
Vanguard Total Stock Mkt Idx 2181979 2.52% 5812 0.27% 2018-07-31
Neuberger Berman Genesis Inv 858104 0.99% -28365 -3.20% 2018-06-30
PowerShares QQQ ETF 711677 0.81% -2760 -0.39% 2018-09-13
Columbia Select Large Cap Growth Z 398516 0.46% -47820 -10.71% 2018-07-31
Franklin DynaTech Fund A 425000 0.49% 25000 6.25% 2018-07-31
American Century Ultra 546000 0.63% -36000 -6.19% 2018-06-30
Vanguard Mid-Cap Growth ETF 527395 0.61% 2273 0.43% 2018-07-31
Fidelity Spartan 578611 0.67% 6824 1.19% 2018-07-31
T. Rowe Price New Horizons 670987 0.77% -60400 -8.26% 2018-06-30
Baron Small Cap Retail 675000 0.78% -25000 -3.57% 2018-06-30
Vanguard Growth Index Inv 611774 0.71% -1777 -0.29% 2018-07-31
Federated Kaufmann Large Cap A 393000 0.45% -- -- 2017-12-31
T. Rowe Price Mid-Cap Growth 350000 0.40% -- -- 2017-12-31
Eaton Vance Atlanta Capital SMID-Cap I 1792425 2.00% -- -- 2016-12-31
Vanguard Extended Market Idx Inv 1060981 1.18% 32154 3.13% 2016-12-31
JPMorgan Small Cap Equity A 589165 0.66% 30393 5.44% 2016-12-31
Federated Kaufmann R 500000 0.56% -- -- 2016-09-30
Royce Premier Invmt 382900 0.43% -107000 -21.84% 2016-12-31
SPDR® S&P MIDCAP 400 ETF 942069 1.00% 42909 4.80% 2015-10-31
Vanguard Extended Market Index Fund 943314 1.00% 9500 1.00% 2015-10-31
Royce Premier Fund 1084200 1.20% 93400 9.40% 2015-09-30
Eaton Vance Atlanta Capital SMID-Cap Fd 1414610 1.50% -- -- 2015-06-30
iShares Core S&P Mid-Cap (AU) 1606047 1.80% 864 -- 2015-11-27
T. Rowe Price Mid-Cap Growth Fund 2500000 2.70% -- -- 2015-09-30
Sequoia Fund 3140822 3.40% -- -- 2015-06-30

James F. Polewaczyk James F. Polewaczyk is Vice President for IDEXX Laboratories, Inc. In the past Mr. Polewaczyk held the position of GM-Medical Consumables & Sensor Business at Philips Medical Systems. He received an undergraduate degree from Worcester Polytechnic Institute and an MBA from Boston University.
Daniel M. Junius Currently, Daniel M. Junius is Chief Financial Officer at Deluxepinpoint Co. Mr. Junius is also on the board of IDEXX Laboratories, Inc. and GlycoMimetics, Inc. and Treasurer & Director at Biotechnology Innovation Organization. He previously occupied the position of Director at ImmunoGen, Inc., Chief Financial Officer & Executive Vice President at Deluxe Business Operations, Inc. and Chief Financial Officer & Vice President of Nashua Corp. Daniel M. Junius received an undergraduate degree from Boston College and a graduate degree from Kellogg School of Management.
M. Anne Szostak Founder of Szostak Partners LLC, M. Anne Szostak is a businessperson who has been at the head of 6 different companies and is President & Chief Executive Officer at this company. She is also on the board of 8 other companies. In the past Ms. Szostak was Chairman & Chief Executive Officer for Fleet Bank (Rhode Island), NA, Chairman, President & Chief Executive Officer of Fleet Maine, NA, EVP, Director-Human Resources & Diversity at FleetBoston Financial Corp., Chairman of Women & Infants Corp. and Chairman for Women & Infants Hospital of Rhode Island. M. Anne Szostak received an undergraduate degree from Colby College.
Rebecca M. Henderson Rebecca M. Henderson is on the board of Amgen, Inc., IDEXX Laboratories, Inc. and Business & Environment Initiative and Associate at National Bureau of Economic Research, Inc., Co-Director-Business Environment Initiative at Harvard Business School and Professor at Harvard University. In her past career Rebecca M. Henderson was Professor at MIT Sloan School of Management and Professor at Massachusetts Institute of Technology. Dr. Henderson received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Harvard University.
Lawrence D. Kingsley Lawrence D. Kingsley is on the board of Microfluidics International Corp. and 4 other companies. In the past Mr. Kingsley held the position of Non-Executive Chairman for IDEX Corp., President at The Motion Group of Cos., Inc., VP, Group Executive-Sensors & Controls Business at Danaher Corp. and Chairman & Chief Executive Officer for Pall Corp. (a subsidiary of Danaher Corp.), GM-Industrial & Commercial Products Division at Kollmorgen Corp. and Principal at W Interconnections, Inc. Lawrence D. Kingsley received an undergraduate degree from Clarkson University and an MBA from The College of William & Mary.
James F. Polewaczyk James F. Polewaczyk is Vice President for IDEXX Laboratories, Inc. In the past Mr. Polewaczyk held the position of GM-Medical Consumables & Sensor Business at Philips Medical Systems. He received an undergraduate degree from Worcester Polytechnic Institute and an MBA from Boston University.
James F. Polewaczyk James F. Polewaczyk is Vice President for IDEXX Laboratories, Inc. In the past Mr. Polewaczyk held the position of GM-Medical Consumables & Sensor Business at Philips Medical Systems. He received an undergraduate degree from Worcester Polytechnic Institute and an MBA from Boston University.
Giovani Twigge Giovani Twigge is Chief Human Resources Officer & Vice President at IDEXX Laboratories, Inc. In his past career he occupied the position of Divisional Vice President-Human Resources at Abbott Nutrition Manufacturing, Inc. and Divisional Vice President-Human Resources at Abbott Diagnostics, Inc. Mr. Twigge received an undergraduate degree from the University of Pretoria.
George J. Fennell Currently, George J. Fennell occupies the position of Vice President at IDEXX Laboratories, Inc. In the past he was Vice President-Animal Genetics & Diagnostics at Zoetis, Inc., Business Director at Wyeth Holdings LLC and Manager-Product Marketing Strategy at BASF Corp. Mr. Fennell received an undergraduate degree from the University of Delaware.
Bruce L. Claflin Bruce L. Claflin founded Kids First (Virgin Islands). He is on the board of IDEXX Laboratories, Inc. and Ciena Corp. and President & Director at Kids First (Virgin Islands). In the past Mr. Claflin was Independent Director at Advanced Micro Devices, Inc., General Manager-Products & Brand Management at International Business Machines Corp. and President for IBM PC Co. (a subsidiary of International Business Machines Corp.), President, Chief Executive Officer & Director at 3Com Corp., President for 3Com Ventures, Inc. and Senior Vice President-Sales & Marketing for Digital Equipment Corp. Mr. Claflin received an undergraduate degree from The Pennsylvania State University.
Stuart M. Essig Presently, Ken Grady occupies the position of Chief Information Officer & Vice President at IDEXX Laboratories, Inc. In his past career Mr. Grady was Chief Information Officer of New England Biolabs, Inc. and Global Head-Business Analytics at Novartis Vaccines & Diagnostics, Inc. Mr. Grady received an undergraduate degree from Georgia Institute of Technology.
Rebecca M. Henderson Rebecca M. Henderson is on the board of Amgen, Inc., IDEXX Laboratories, Inc. and Business & Environment Initiative and Associate at National Bureau of Economic Research, Inc., Co-Director-Business Environment Initiative at Harvard Business School and Professor at Harvard University. In her past career Rebecca M. Henderson was Professor at MIT Sloan School of Management and Professor at Massachusetts Institute of Technology. Dr. Henderson received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Harvard University.
Brian Patrick McKeon Currently, Brian Patrick McKeon is Chief Financial Officer, Treasurer & Executive VP of IDEXX Laboratories, Inc. and Chief Financial Officer for Iron Mountain Information Management, Inc. He is also on the board of IDEXX Laboratories Ltd. and IDEXX UK Acquisition Ltd. In his past career Mr. McKeon held the position of Manager-Strategic Planning at PepsiCo, Inc. and Vice President-Finance at Pepsi-Cola North America (a subsidiary of PepsiCo, Inc.), Senior VP-Worldwide Consulting Services at J.D. Edwards, Inc., VP-Delivery & Center Project Performance at CMTSU Liquidation, Inc., Chief Financial Officer & Executive Vice President at Iron Mountain, Inc., Chief Financial Officer & EVP-Administration at Timberland LLC, Chief Financial Officer & Senior Vice President for Amazon.com LLC and Auditor for Coopers & Lybrand LLP. Brian Patrick McKeon received an undergraduate degree from the University of Connecticut and an MBA from Harvard University.
Sophie V. Vandebroek Sophie V. Vandebroek is on the board of IDEXX Laboratories, Inc. and Worcester Polytechnic Institute and Member of Women in Technology International, Member of Koninklijke Vlaamse Academie van Belgi�0�1�0�0 voor Wetenschappen en and Vice President-Emerging Technology Partnerships at International Business Machines Corp. She previously was CTO & President-Xerox Innovation Group at Xerox Corp. and Vice President at Xerox Engineering Center (a subsidiary of Xerox Corp.) and Chief Technology Officer for Carrier Corp. Dr. Vandebroek received a doctorate from Cornell University and a graduate degree and an undergraduate degree from Katholieke Universiteit Leuven.
Daniel M. Junius Currently, Daniel M. Junius is Chief Financial Officer at Deluxepinpoint Co. Mr. Junius is also on the board of IDEXX Laboratories, Inc. and GlycoMimetics, Inc. and Treasurer & Director at Biotechnology Innovation Organization. He previously occupied the position of Director at ImmunoGen, Inc., Chief Financial Officer & Executive Vice President at Deluxe Business Operations, Inc. and Chief Financial Officer & Vice President of Nashua Corp. Daniel M. Junius received an undergraduate degree from Boston College and a graduate degree from Kellogg School of Management.
Jonathan J. Mazelsky Jonathan J. Mazelsky is President, Chief Executive Officer & Executive VP at IDEXX Laboratories, Inc. In the past Mr. Mazelsky held the position of General Manager for Agilent Technologies, Inc. and SVP, GM-Computed Tomography & Nuclear Medicine at Philips Medical Systems (Cleveland), Inc. He received an undergraduate degree from the University of Rochester and an MBA from The University of Chicago.
Sharon E. Underberg Currently, Sharon E. Underberg occupies the position of Secretary, Vice President & General Counsel for IDEXX Laboratories, Inc. In the past Ms. Underberg occupied the position of Secretary, Senior Vice President & General Counsel for Eastman Kodak Co. and Attorney at Norton Rose Fulbright US LLP. Ms. Underberg received an undergraduate degree from Brandeis University and a graduate degree from The University of Pennsylvania Law School.
Pat Venters Currently, Pat Venters is Chief Marketing Officer & Vice President at IDEXX Laboratories, Inc.
Sam A. Samad Mr. Sam A. Samad is an Independent Director at IDEXX Laboratories, Inc. and a Chief Financial Officer & Senior Vice President at Illumina, Inc. He is on the Board of Directors at IDEXX Laboratories, Inc. Mr. Samad was previously employed as a Treasurer & Senior Vice President by Cardinal Health, Inc. He received his undergraduate degree from American University of Beirut and an MBA from McMaster University.
Ken Grady Presently, Ken Grady occupies the position of Chief Information Officer & Vice President at IDEXX Laboratories, Inc. In his past career Mr. Grady was Chief Information Officer of New England Biolabs, Inc. and Global Head-Business Analytics at Novartis Vaccines & Diagnostics, Inc. Mr. Grady received an undergraduate degree from Georgia Institute of Technology.
Ken Grady Presently, Ken Grady occupies the position of Chief Information Officer & Vice President at IDEXX Laboratories, Inc. In his past career Mr. Grady was Chief Information Officer of New England Biolabs, Inc. and Global Head-Business Analytics at Novartis Vaccines & Diagnostics, Inc. Mr. Grady received an undergraduate degree from Georgia Institute of Technology.
Jeffrey Thomas Currently, Jeffrey Thomas occupies the position of Chief Technology Officer & Vice President at IDEXX Laboratories, Inc. He previously was Director-Research & Development at Dako Corp. He received an undergraduate degree from the University of Utah and an MBA from MIT Sloan School of Management.
Kathy V. Turner Kathy V. Turner is Corporate Vice President at IDEXX Laboratories, Inc.
Michael Lane Michael Lane is Vice President at IDEXX Laboratories, Inc.
Tina Hunt Tina Hunt is Corporate Vice President at IDEXX Laboratories, Inc.
John Ravis Presently, John Ravis holds the position of Head-Investor relations of IDEXX Laboratories, Inc.
John Hart John Hart is Vice President-Worldwide Operations at IDEXX Laboratories, Inc. Mr. Hart received an undergraduate degree from Bowdoin College and an MBA from New York University.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐